Q BioMed
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Q BioMed's past years’ income statements indicate that its last revenue has increased compared to the previous period by 45% to $284,352. The net income raised on -$716,095 and profit margin reached -252%. Total operating expenses were $3,436,627.

Profit Margin

Q BioMed Inc. (OTC:QBIO): Profit margin
2013 0 -500
2014 0 -38.05K
2015 0 -1.08M
2016 0 -7.17M
2017 0 -14.54M
2018 0 -9.27M
2019 0 -11.74M
2020 30K -13.78M -45961.35%
2021 195.59K -8.74M -4472.19%
2022 284.35K -716.09K -251.83%

QBIO Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
284.35K195.59K30K0000000
Cost of revenue
293.34K246.84K326.00K50K000038.05K0
Gross profit
-8.98K-51.24K-296.00K-50K0000-38.05K0
Operating exp.
Research and development
125.37K1.07M1.88M3.53M3.23M3.09M1.31M598K00
Selling and marketing
0000000000
Total operating expenses
3.43M7.33M12.84M8.01M9.01M12.37M6.34M952.13K38.05K500
Operating income
-3.44M-7.38M-13.14M-8.01M-9.01M-12.37M-6.34M-952.13K-38.05K-500
Other income (expenses), net
1.39M-851.98K-346.77K-2.25M-89K-2.16M-344.71K-134.47K00
Income before tax
-2.05M-8.24M-13.49M-10.27M-9.27M-14.54M-7.17M-1.08M-38.05K-500
Income tax expense
-1.33M506.92K296.21K1.46M251.10K760.17K0-937.62K00
Net income
-716.09K-8.74M-13.78M-11.74M-9.27M-14.54M-7.17M-1.08M-38.05K-500
Earnings per share
Basic EPS
-0.01-0.33-0.62-0.78-0.67-1.39-0.81-0.12-0.00-0.00
Diluted EPS
-0.01-0.33-0.62-0.78-0.67-1.39-0.81-0.12-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source